|
May 30
|
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
|
|
May 29
|
SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal
|
|
May 29
|
U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot
|
|
May 28
|
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
|
|
May 3
|
Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations
|
|
May 2
|
Sector Update: Health Care Stocks Higher Friday Afternoon
|
|
May 2
|
Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises
|
|
May 2
|
Q1 2025 Adaptive Biotechnologies Corp Earnings Call
|
|
May 2
|
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...
|
|
May 1
|
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 1
|
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
Adaptive Biotechnologies: Q1 Earnings Snapshot
|
|
May 1
|
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
|
|
Mar 11
|
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
|
|
Jan 17
|
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
|
|
Jan 16
|
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
|
|
Jan 2
|
Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 1
|
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
|